📢 Publication alert 👉🩸
Thrilled to share our latest findings from the #DROPAD project on using capillary finger #blood for the detection of #progranulin that can identify mutation carriers in FTD! #Biomarkers#DROPAD
https://t.co/3RMGBrY3WM
Massive paper alert: We performed extensive profiling of PI-2620 for 4R tauopathies. PI-2620 tau PET signals in PSP stem from neuronal and oligodendroglial tau, not astrocytes. Signals correlate with fibrillary tau, autoradiography, and autopsy data in PSP https://t.co/zEF9fwBlsN
Please join us in Gothenburg on January 30 for a symposium on recent advances in the cognitive assessment of neurodegenerative diseases! We are excited to host a truly excellent panel of lecturers!
Please register free of charge by email to [email protected]#ENDALZ
Congratulations to @JosephTherr and colleagues on their great work! The results of Alzheimer disease blood tests must be integrated with clinical data to understand the certainty of test results and formulate next clinical steps. #ENDALZ
https://t.co/3QnlQDOThT
@OskarHansson9 @biofinder_study@RikOssenkoppele@NiklasMattsson4@SebastianPalmqv Tack så mycket, Oskar, I appreciate it!! Thank you for your mentorship in the past two years, and indeed our great discussions and light moments too 🙏 Lycka till i Lund and see you soon in the future 🙌
🚨New publication led by @LECollij ‼️
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease” shows the exacerbating effects of a-synuclein co-pathology in Alzheimer's disease. Now published in @NatureComms !
https://t.co/Vy1rRbVsiS